Clinical and Behavioral Outcomes for Transgender Women Engaged in HIV Care: Comparisons to Cisgender Men and Women in the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) Cohort

Overview

Journal AIDS Behav

Specialty Infectious Diseases

Date 2023 Jan 7

PMID 36609705

Authors

Sari L Reisner

Bridget M Whitney

Heidi M Crane

Kenneth H Mayer

Chris Grasso

Robin M Nance

Tonia Poteat

W Chris Mathews

Katerina Christopoulos

Michael J Mugavero

Geetanjali Chander

Joseph J Eron

Mari M Kitahata

Joseph A C Delaney

Rob J Fredericksen

Affiliations

Soon will be listed here.

Abstract

Describe health of transgender women (TW) with HIV vs. cisgender men and women (CM, CW) in a U.S. HIV care cohort. Data were from Centers for AIDS Research Network of Integrated Clinical Systems (CNICS), 2005-2022. TW were identified using clinical data/identity measures. PWH (n = 1285) were included in analyses (275 TW, 547 CM, 463 CW). Cross-sectional multivariable analyses compared HIV outcomes/co-morbidities between TW/CM and TW/CW, and adjusted odds ratios (aOR) and 95% confidence intervals (95% CI) were estimated. TW had poorer adherence (> 90% adherent; aOR 0.57; 95%CI 0.38, 0.87) and were more likely to miss ≥ 3 visits in the past year than CM (aOR 1.50, 95%CI 1.06, 2.10); indicated more anxiety compared to both CM and CW (p ≤ 0.001, p = 0.02); hepatitis C infection (p = 0.03) and past-year/lifetime substance treatment (p = 0.004/p = 0.001) compared to CM; and substance use relative to CW. TW with HIV differed in HIV clinical outcomes and co-morbidities from CM and CW.

Citing Articles

Prevalence and Correlates of Hepatitis C Viremia Among People With Human Immunodeficiency Virus in the Direct-Acting Antiviral Era.

Ma J, Nance R, Cachay E, Ruderman S, Kitahata M, Falade-Nwulia O Open Forum Infect Dis. 2025; 12(2):ofaf030.

PMID: 39896988 PMC: 11786118. DOI: 10.1093/ofid/ofaf030.

HIV and hepatitis C virus infection and co-infection among trans women in San Francisco, 2020.

Chiu I, Cano D, Leathers M, Turner C, Trujillo D, Sicro S PLoS One. 2024; 19(9):e0307990.

PMID: 39312538 PMC: 11419358. DOI: 10.1371/journal.pone.0307990.

References

The Lancet Hiv . U=U taking off in 2017. Lancet HIV. 2017; 4(11):e475. DOI: 10.1016/S2352-3018(17)30183-2. View

Newcombe D, Humeniuk R, Ali R . Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site. Drug Alcohol Rev. 2005; 24(3):217-26. DOI: 10.1080/09595230500170266. View

Rebchook G, Keatley J, Contreras R, Perloff J, Molano L, Reback C . The Transgender Women of Color Initiative: Implementing and Evaluating Innovative Interventions to Enhance Engagement and Retention in HIV Care. Am J Public Health. 2017; 107(2):224-229. PMC: 5227951. DOI: 10.2105/AJPH.2016.303582. View

Reisner S, Radix A, Deutsch M . Integrated and Gender-Affirming Transgender Clinical Care and Research. J Acquir Immune Defic Syndr. 2016; 72 Suppl 3:S235-42. PMC: 4969060. DOI: 10.1097/QAI.0000000000001088. View

Spitzer R, Kroenke K, Williams J . Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999; 282(18):1737-44. DOI: 10.1001/jama.282.18.1737. View

Langenderfer-Magruder L, Walls N, Kattari S, Whitfield D, Ramos D . Sexual Victimization and Subsequent Police Reporting by Gender Identity Among Lesbian, Gay, Bisexual, Transgender, and Queer Adults. Violence Vict. 2016; 31(2):320-31. DOI: 10.1891/0886-6708.VV-D-14-00082. View

Beckwith C, Kuo I, Fredericksen R, Brinkley-Rubinstein L, Cunningham W, Springer S . Risk behaviors and HIV care continuum outcomes among criminal justice-involved HIV-infected transgender women and cisgender men: Data from the Seek, Test, Treat, and Retain Harmonization Initiative. PLoS One. 2018; 13(5):e0197730. PMC: 5963777. DOI: 10.1371/journal.pone.0197730. View

Santos G, Wilson E, Rapues J, Macias O, Packer T, Raymond H . HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study. Sex Transm Infect. 2014; 90(5):430-3. DOI: 10.1136/sextrans-2013-051342. View

Gamarel K, Brown L, Kahler C, Fernandez M, Bruce D, Nichols S . Prevalence and correlates of substance use among youth living with HIV in clinical settings. Drug Alcohol Depend. 2016; 169:11-18. PMC: 5140709. DOI: 10.1016/j.drugalcdep.2016.10.002. View

10.

Baguso G, Gay C, Lee K . Medication adherence among transgender women living with HIV. AIDS Care. 2016; 28(8):976-81. PMC: 4917432. DOI: 10.1080/09540121.2016.1146401. View

11.

Mizuno Y, Beer L, Huang P, Frazier E . Factors Associated with Antiretroviral Therapy Adherence Among Transgender Women Receiving HIV Medical Care in the United States. LGBT Health. 2017; 4(3):181-187. PMC: 6711391. DOI: 10.1089/lgbt.2017.0003. View

12.

Kroenke K, Spitzer R, Williams J . The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9):606-13. PMC: 1495268. DOI: 10.1046/j.1525-1497.2001.016009606.x. View

13.

Nemoto T, Bodeker B, Iwamoto M . Social support, exposure to violence and transphobia, and correlates of depression among male-to-female transgender women with a history of sex work. Am J Public Health. 2011; 101(10):1980-8. PMC: 3222349. DOI: 10.2105/AJPH.2010.197285. View

14.

Sevelius J, Patouhas E, Keatley J, Johnson M . Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. 2013; 47(1):5-16. PMC: 3925767. DOI: 10.1007/s12160-013-9565-8. View

15.

Fredericksen R, Mayer K, Gibbons L, Edwards T, Yang F, Walcott M . Development and Content Validation of a Patient-Reported Sexual Risk Measure for Use in Primary Care. J Gen Intern Med. 2018; 33(10):1661-1668. PMC: 6153230. DOI: 10.1007/s11606-018-4496-5. View

16.

Yehia B, Fleishman J, Moore R, Gebo K . Retention in care and health outcomes of transgender persons living with HIV. Clin Infect Dis. 2013; 57(5):774-6. PMC: 3739465. DOI: 10.1093/cid/cit363. View

17.

Dank M, Lachman P, Zweig J, Yahner J . Dating violence experiences of lesbian, gay, bisexual, and transgender youth. J Youth Adolesc. 2013; 43(5):846-57. DOI: 10.1007/s10964-013-9975-8. View

18.

Sevelius J, Chakravarty D, Neilands T, Keatley J, Shade S, Johnson M . Evidence for the Model of Gender Affirmation: The Role of Gender Affirmation and Healthcare Empowerment in Viral Suppression Among Transgender Women of Color Living with HIV. AIDS Behav. 2019; 25(Suppl 1):64-71. PMC: 9351439. DOI: 10.1007/s10461-019-02544-2. View

19.

Gilbert P, Pass L, Keuroghlian A, Greenfield T, Reisner S . Alcohol research with transgender populations: A systematic review and recommendations to strengthen future studies. Drug Alcohol Depend. 2018; 186:138-146. PMC: 5911250. DOI: 10.1016/j.drugalcdep.2018.01.016. View

20.

Poteat T, Scheim A, Xavier J, Reisner S, Baral S . Global Epidemiology of HIV Infection and Related Syndemics Affecting Transgender People. J Acquir Immune Defic Syndr. 2016; 72 Suppl 3:S210-9. PMC: 4969059. DOI: 10.1097/QAI.0000000000001087. View